The purpose of this project is to develop a cellular assay specific to circadian rhythm defects identified by the Reiter laboratory. The eventual goal is to use this assay to screen for compounds that can normalize these circadian defects, potentially identifying drugs that would address developmental and metabolic changes that accompany circadian rhythm defects in Prader-Willi (PWS) and Schaaf-Yang (SYS) syndromes.